- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/12 - Viral antigens
Patent holdings for IPC class A61K 39/12
Total number of patents in this class: 9924
10-year publication summary
|
540
|
591
|
642
|
751
|
687
|
735
|
720
|
662
|
640
|
389
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1650 |
240 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2869 |
195 |
| The Trustees of the University of Pennsylvania | 4337 |
140 |
| Janssen Vaccines & Prevention B.V. | 310 |
134 |
| Intervet Inc. | 910 |
126 |
| Intervet International B.V. | 1295 |
117 |
| Takeda Vaccines, Inc. | 222 |
106 |
| Zoetis Services LLC | 1536 |
106 |
| Modernatx, Inc. | 1284 |
95 |
| Inovio Pharmaceuticals, Inc. | 322 |
84 |
| Boehringer Ingelheim Animal Health USA Inc. | 426 |
83 |
| The Regents of the University of California | 20059 |
82 |
| Boehringer Ingelheim Vetmedica GmbH | 1278 |
76 |
| Immatics Biotechnologies GmbH | 1153 |
76 |
| Institut Pasteur | 783 |
71 |
| Duke University | 3087 |
69 |
| The Wistar Institute of Anatomy and Biology | 454 |
66 |
| Pfizer Inc. | 3368 |
61 |
| Massachusetts Institute of Technology | 10102 |
60 |
| Bavarian Nordic A/S | 261 |
60 |
| Other owners | 7877 |